KSR2 presents an enticing therapeutic target [13], as mutations (some of which locate to the PKD) in KSR2 affect energy balance and are associated with numerous diseases, like obesity and related metabolic problems [72]. This evidence concerns the gene KSR2 and obesity due to melanocortin 4 receptor deficiency.